View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/CDC | RIN: 0920-AA87 | Publication ID: 2026 |
| Title: Control of Communicable Diseases; Foreign Quarantine: Dog Importation | |
|
Abstract:
This proposed rule addresses the public health risk of dog-maintained rabies virus variant (DMRVV) associated with the importation of dogs into the United States. In this rule, HHS/CDC proposes revisions and clarifications to the requirements for the importation of dogs. |
|
| Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: No | Unfunded Mandates: No |
| EO 14192 Designation: Deregulatory | |
| CFR Citation: 42 CFR 71 | |
| Legal Authority: 42 U.S.C. 264, sec. 361 | |
|
Legal Deadline:
None |
||||||
|
Statement of Need: Following publication of a related final rule in May 2024, CDC received considerable feedback regarding the rule’s requirements for dogs entering from low risk and rabies-free countries. In response, CDC quickly implemented temporary flexibilities prior to the rule’s effective date. Implementing these temporary flexibilities alleviated the most pressing concerns regarding burden and prevented travel disruptions. Targeted modification of these regulatory requirements is needed to ensure that they are proportionate to the public health risk. By refining these requirements, we can strike a better balance between protecting public health and minimizing unnecessary burden importers from low-risk and rabies-free countries. This approach acknowledges a minimal increase in the possibility of fraudulent importation, but the benefits are substantial: improved public compliance, streamlined processes, and significantly reduced burden for those importing dogs from the lowest-risk countries. In addition to alleviating the burden of individuals importing dogs, we are also working closely with airlines to provide additional flexibilities for air waybill requirements. Congressional and interagency partners (including Department of State), foreign governments, airlines, rescue groups, disability advocates, and breeders have welcomed the temporary flexibilities and remain interested in maintaining simpler and less burdensome importation requirements in the long-term. |
||||||
|
Summary of the Legal Basis: The primary legal authority supporting this proposed rule is section 361 of the Public Health Service Act (PHS Act) (42 U.S.C. 264). Under section 361, the Secretary of HHS (Secretary) may make and enforce such regulations as in the Secretary's judgment are necessary to prevent the introduction, transmission, or spread of communicable diseases from foreign countries into the United States and from one State or possession into any other State or possession. It also authorizes the Secretary to promulgate and enforce a variety of public health regulations to prevent the spread of communicable diseases, including through inspection, fumigation, disinfection, sanitation, pest extermination, destruction of animals or articles found to be sources of dangerous infection to human beings, and other measures. Since at least 1956, federal quarantine regulations (currently found at 42 CFR 71.51) have controlled the entry of dogs and cats into the United States. |
||||||
|
Alternatives: We have considered maintaining existing dog importation requirements, which would provide the highest level of protection against the importation of DRMVV. However, we have determined that reducing the requirements for low-risk dog importations would substantially lower burden while retaining appropriate public health protections. This approach aligns with Section 4(c)(1)(B) of Executive Order 12866, which calls for regulations to be tailored to the level of risk and to avoid imposing unnecessary costs. Furthermore, maintaining current requirements would conflict with the mandate in Executive Order 14219 to reduce regulatory burdens wherever possible. |
||||||
|
Anticipated Costs and Benefits: While formal economic estimates are still in progress, CDC’s preliminary analysis indicates that the proposed revisions to 42 CFR 71.51 will generate substantial cost savings and increased flexibilities for individual travelers, government agencies, and commercial airlines. Current estimates suggest that these changes could result in annualizednet cost-savings of $5-$43 million. The primary source of cost savings stems from streamlining documentation requirements for dogs imported from rabies-free and low-risk countries. By streamlining these requirements, the rule will significantly reduce administrative, compliance, and processing costs for importers. Instead, the only requirement will be a CDC Dog Import Form receipt. In addition to the cost-savings, the proposed changes will enhance travel flexibility for individuals and organizations, making it easier to import dogs from low-risk countries without unnecessary delays or disruptions. |
||||||
|
Risks: Adopting reduced documentation requirements for dogs imported from low-risk and rabies-free countries is a targeted approach that aligns regulatory oversight with the public health risk posed by these importations. The primary risk associated with this approach is a small increase in the possibility of fraudulent importation attempts, such as falsified documentation or misrepresentation of a dog’s country of origin or rabies status. However, this risk is mitigated by several factors:
This approach is consistent with Section 4(c)(1)(D) of Executive Order 12866, which directs agencies to ensure that regulations are proportionate to the risks addressed. By focusing regulatory efforts where they are most needed, we maintain effective public health protections while minimizing unnecessary burdens. |
||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Federal, Local, State |
| Small Entities Affected: Businesses, Organizations | Federalism: No |
| Included in the Regulatory Plan: Yes | |
| International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Ashley C. Altenburger JD Regulatory Analyst Department of Health and Human Services Centers for Disease Control and Prevention 1600 Clifton Road NE, MS: H16-4, Atlanta, GA 30307 Phone:800 232-4636 Email: dgmqpolicyoffice@cdc.gov |
|
An official website of the United States government




